- Home
- IMVT vs WB Comparison
IMVT vs WB Comparison
Compare IMVT & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- WB
- Stock Information
- Founded
- IMVT 2018
- WB 2009
- Country
- IMVT United States
- WB China
- Employees
- IMVT N/A
- WB N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- WB Computer Software: Programming Data Processing
- Sector
- IMVT Health Care
- WB Technology
- Exchange
- IMVT Nasdaq
- WB Nasdaq
- Market Cap
- IMVT 2.7B
- WB 2.8B
- IPO Year
- IMVT N/A
- WB 2014
- Fundamental
- Price
- IMVT $16.16
- WB $12.25
- Analyst Decision
- IMVT Buy
- WB Buy
- Analyst Count
- IMVT 11
- WB 2
- Target Price
- IMVT $33.88
- WB $14.00
- AVG Volume (30 Days)
- IMVT 1.5M
- WB 1.4M
- Earning Date
- IMVT 11-06-2025
- WB 08-14-2025
- Dividend Yield
- IMVT N/A
- WB 13.38%
- EPS Growth
- IMVT N/A
- WB 9.65
- EPS
- IMVT N/A
- WB 1.41
- Revenue
- IMVT N/A
- WB $1,762,960,000.00
- Revenue This Year
- IMVT N/A
- WB $1.33
- Revenue Next Year
- IMVT N/A
- WB $2.25
- P/E Ratio
- IMVT N/A
- WB $8.42
- Revenue Growth
- IMVT N/A
- WB 1.37
- 52 Week Low
- IMVT $12.72
- WB $7.10
- 52 Week High
- IMVT $32.10
- WB $12.40
- Technical
- Relative Strength Index (RSI)
- IMVT 51.87
- WB 63.95
- Support Level
- IMVT $16.08
- WB $11.51
- Resistance Level
- IMVT $17.20
- WB $12.32
- Average True Range (ATR)
- IMVT 0.77
- WB 0.35
- MACD
- IMVT 0.16
- WB 0.03
- Stochastic Oscillator
- IMVT 58.68
- WB 95.10
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.